Boston Scientific Corp. vs. Sight Sciences, Inc. Common Stock
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BSX | SGHT | |
|---|---|---|
| Market Cap | $71.46 billion | $411.51 million |
| Revenue (TTM) | $21.00 billion | $83.38 million |
| Net Income (TTM) | $3.67 billion | $-29,757,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | SGHT | |
|---|---|---|
| P/E Ratio | 19.96 | — |
| Price / Book | 2.84 | 7.78 |
| Price / Sales | 3.40 | 4.94 |
BSX leads on 2 of 2 valuation factors.
Profitability
| BSX | SGHT | |
|---|---|---|
| Net Margin | 17.47% | -35.69% |
| Return on Equity | 14.58% | -56.26% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | SGHT | |
|---|---|---|
| Short Interest | 0.72% | 0.44% |
SGHT leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, SGHT overview, SGHT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.